Elicio Therapeutics Stock Market Value
| ELTX Stock | 5.12 0.11 2.20% |
| Symbol | Elicio |
Elicio Therapeutics Price To Book Ratio
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elicio Therapeutics. If investors know Elicio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elicio Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.44) | Return On Assets (0.97) | Return On Equity (3.53) |
The market value of Elicio Therapeutics is measured differently than its book value, which is the value of Elicio that is recorded on the company's balance sheet. Investors also form their own opinion of Elicio Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Elicio Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elicio Therapeutics' market value can be influenced by many factors that don't directly affect Elicio Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Elicio Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Elicio Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elicio Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Elicio Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Elicio Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Elicio Therapeutics.
| 05/26/2024 |
| 11/22/2024 |
If you would invest 0.00 in Elicio Therapeutics on May 26, 2024 and sell it all today you would earn a total of 0.00 from holding Elicio Therapeutics or generate 0.0% return on investment in Elicio Therapeutics over 180 days. Elicio Therapeutics is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. Elicio Therapeutics is entity of United States More
Elicio Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Elicio Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Elicio Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.79 | |||
| Information Ratio | 0.0354 | |||
| Maximum Drawdown | 28.39 | |||
| Value At Risk | (5.22) | |||
| Potential Upside | 8.23 |
Elicio Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Elicio Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Elicio Therapeutics' standard deviation. In reality, there are many statistical measures that can use Elicio Therapeutics historical prices to predict the future Elicio Therapeutics' volatility.| Risk Adjusted Performance | 0.0498 | |||
| Jensen Alpha | 0.3019 | |||
| Total Risk Alpha | (0.30) | |||
| Sortino Ratio | 0.0457 | |||
| Treynor Ratio | (0.51) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Elicio Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Elicio Therapeutics Backtested Returns
Elicio Therapeutics appears to be moderately volatile, given 3 months investment horizon. Elicio Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0718, which denotes the company had a 0.0718% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Elicio Therapeutics, which you can use to evaluate the volatility of the firm. Please utilize Elicio Therapeutics' Mean Deviation of 3.45, coefficient of variation of 1820.95, and Downside Deviation of 3.79 to check if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Elicio Therapeutics holds a performance score of 5. The firm shows a Beta (market volatility) of -0.51, which means possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Elicio Therapeutics are expected to decrease at a much lower rate. During the bear market, Elicio Therapeutics is likely to outperform the market. Please check Elicio Therapeutics' sortino ratio, as well as the relationship between the semi variance and rate of daily change , to make a quick decision on whether Elicio Therapeutics' price patterns will revert.
Auto-correlation | -0.69 |
Very good reverse predictability
Elicio Therapeutics has very good reverse predictability. Overlapping area represents the amount of predictability between Elicio Therapeutics time series from 26th of May 2024 to 24th of August 2024 and 24th of August 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Elicio Therapeutics price movement. The serial correlation of -0.69 indicates that around 69.0% of current Elicio Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.69 | |
| Spearman Rank Test | -0.2 | |
| Residual Average | 0.0 | |
| Price Variance | 0.19 |
Elicio Therapeutics lagged returns against current returns
Autocorrelation, which is Elicio Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Elicio Therapeutics' stock expected returns. We can calculate the autocorrelation of Elicio Therapeutics returns to help us make a trade decision. For example, suppose you find that Elicio Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Elicio Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Elicio Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Elicio Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Elicio Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Elicio Therapeutics Lagged Returns
When evaluating Elicio Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Elicio Therapeutics stock have on its future price. Elicio Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Elicio Therapeutics autocorrelation shows the relationship between Elicio Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Elicio Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Elicio Stock Analysis
When running Elicio Therapeutics' price analysis, check to measure Elicio Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Elicio Therapeutics is operating at the current time. Most of Elicio Therapeutics' value examination focuses on studying past and present price action to predict the probability of Elicio Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Elicio Therapeutics' price. Additionally, you may evaluate how the addition of Elicio Therapeutics to your portfolios can decrease your overall portfolio volatility.